Key result
Tricuspid TEER effectively treats TR but faces limitations from unique anatomical and pathological characteristics.
Why the study?
T-TEER is the most frequently used transcatheter therapy for TR, but its efficacy and technical benefits face limitations due to unique anatomical characteristics and pathological mechanisms of the tricuspid valve.
T-TEER is a promising but anatomically challenging transcatheter treatment for tricuspid regurgitation that requires further device innovation and refined patient selection.
May support selective T-TEER use; leaves open need for device innovation and refined selection criteria.
INTRODUCTION: Tricuspid regurgitation (TR) is one of the most prevalent types of valvular heart disease linked to poor prognosis in patients with heart failure and is usually ignored. TR has received considerable attention due to the progressive advancements in transcatheter therapies in recent years. AREAS COVERED: With relatively solid data and rapid technological advancements, tricuspid transcatheter edge-to-edge repair (T-TEER) is the most frequently employed in a series of tricuspid transcatheter interventional treatments for TR. However, the efficacy and technical benefits of T-TEER are limited because of the unique anatomical characteristics and pathological mechanisms of the tricuspid valve. The aim of this review is to summarize reported data on current status of T-TEER and to provide an expert opinion regarding the challenges it is now experiencing and future development direction and approach. EXPERT OPINION: T-TEER is a significant treatment for TR, but its effectiveness and technical promotion are limited due to the tricuspid valve unique anatomical characteristics and pathological mechanisms. The selection criteria for suitable patients, the choice of when to intervene, device innovation, the advancement of ultrasound technology, and the volume of evidence in evidence-based medicine all indicate that the disorder of TR will eventually be better treated and understood.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2023) conducted a review in Tricuspid regurgitation (TR). Tricuspid transcatheter edge-to-edge repair (T-TEER) was evaluated. Tricuspid transcatheter edge-to-edge repair is a significant treatment for tricuspid regurgitation, but its effectiveness is limited by unique anatomical and pathological characteristics.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: